Elon Musk's Neuralink said on Monday that it had raised $650 million in its latest funding round as its brain implant device ...

Neuralink just closed a hefty $650 million Series E round, pushing its valuation past the $9 billion mark. Backed by big names like ARK Invest, Founders Fund, Sequoia Capital, QIA and Valor Equity ...

In today’s environment, aligning the Target Product Profile with the appropriate Value Evidence Archetype is not just good ...

Neuralink accelerates its brain-computer interface ambitions with a major funding boost and ongoing human trials.

Muse has reached a major milestone with the recent launch of Muse S Athena, the first wearable to integrate clinical-grade ...

Dementia experts have said that “hope is on the horizon” after a new review shows a rise in the number of potential drugs ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Among the lung cancer population with EGFR mutations, patients with insertions at exon 20 (ex20ins) represent a significant unmet need segment. These patients often have poorer outcomes compared to ...

ClearSight, a leading provider of advanced vision correction solutions, is now offering the PanOptix® Trifocal Intraocular ...

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

Elon Musk's Neuralink said on Monday that it had raised $650 million in its latest funding round as its brain implant device ...

Neuralink closed its funding round with participation from key investors including ARK Invest, DFJ Growth, Founders Fund, G42 ...